Aviva plc
United Kingdom · GB0002162385 · reports in GBP · Europe
The answers
From the annual report for the year to Dec 31, 2024. Each line says what it is based on.
- Is it growing?Good
- Revenue +12% in the year to Dec 31, 2024, on the year before.
- Is it a good business?Fair
- It earned 8.2% on its shareholders' equity in the year to Dec 31, 2024.
- Is it safe?To watch
- Equity is 2% of its assets, and operations brought in cash in the year.
- Is the price fair?n/a
- Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.
The year
Year to Dec 31, 2024, consolidated, in GBP.
revenue
operating margin
net profit
Year by year
As filed; an earlier year can differ from its own report when the company restated it.
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|
| Revenue | n/a | n/a | £18.5B | £20.7B |
| Net profit to shareholders | £2.0B | −£1.2B | £1.1B | £683M |
| Earnings per share | £0.50 | −£0.38 | £37.70 | £23.60 |
| Cash from operations | −£2.9B | £15.9B | −£2.7B | £8.4B |
| Capital spending | £86M | £16M | £149M | £50M |
| Cash | £12.5B | £22.5B | £17.3B | £23.5B |
| Total assets | £358.5B | £315.3B | £328.8B | £353.9B |
| Equity | £19.5B | £12.9B | £9.6B | £8.6B |
What they do
In the company's own words, from the annual report.
transacts life assurance and long-term savings business, fund management and most classes of general insurance and health business through its subsidiaries, joint ventures, associates and branches in the UK, Ireland, Canada, India and China
Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.